Skip to main content
. 2022 Apr 1;2022(4):CD013846. doi: 10.1002/14651858.CD013846.pub2

Seok 1998.

Methods Single‐centre randomized controlled trial
Participants Inclusion criteria
  1. Birthweight < 1500 g

Interventions Active intervention (n = 23)
Indomethacin 0.2 mg/kg initial dose followed by 2 doses of 0.1 mg/kg at 24‐hour intervals. 15 participants received IV formulation and 8 received oral formulation
Control (n = 23)
No placebo
Outcomes Primary outcome: germinal matrix or intraventricular haemorrhage
Notes Primary study location: Il Sin Christian Hospital, Pusan, Korea
Study Period: August 1995 to June 1997
The article is in Korean. We are awaiting translation of the article from Korean to English

GA: gestational age;GI: gastrointestinal; IVH: intraventricular haemorrhage; NEC: necrotizing enterocolitis; PDA: patent ductus arteriosus.